CTRB2

CTRB2

Target · Pancreatic serine protease

CTRB2 Chymotrypsinogen B2

CTRB2 (chymotrypsinogen B2) is a secreted serine protease precursor and a principal precursor of the pancreatic proteolytic enzymes. It is synthesised in pancreatic acinar cells and activated by proteolysis in the small intestine. Browse Assay Genie's current range of CTRB2 research reagents below, or read on for the biology behind the target.

Secreted proteinPeptidase S1 familyLinked to chronic pancreatitis
263 aa
Protein length
~28 kDa
Molecular weight
16q23.1
Gene locus
EC 3.4.21.1
Enzyme class
Target information

What is CTRB2 (chymotrypsinogen B2)?

CTRB2 encodes a member of the serine protease family and forms a principal precursor of the pancreatic proteolytic enzymes. The encoded preproprotein is synthesised in the acinar cells of the pancreas and secreted into the small intestine, where proteolytic activation generates the functional enzyme. As a zymogen, it is held inactive until it reaches the gut, which is the defining feature of this class of digestive enzymes.

The CTRB2 protein belongs to the peptidase S1 family and is assigned EC 3.4.21.1. HGNC places the gene in the chymotrypsins and elastases group. UniProt lists the mature product as secreted into the extracellular space. The CTRB2 gene lies head-to-head with the related CTRB1 gene, so the two genes share a genomic arrangement and are often considered together.

Genetic variation at this locus has been linked to pancreatic disease. Some human populations carry an alternate haplotype that inverts a 16.6 Kb region containing portions of intron 1, exon 1 and the upstream sequence of both CTRB1 and CTRB2. In this haplotype, exon 1 and flanking sequence are swapped between the two genes. The inversion is associated with differential gene expression and increased risk of chronic pancreatitis. SNP rs8048956 is diagnostic for it, and the GRCh38 assembly represents the minor allele of that SNP in the CTRB1 gene.

Pancreatic enzyme biology

CTRB2 is a principal precursor of pancreatic proteolytic enzymes, making it relevant to studies of digestive protease synthesis and secretion by acinar cells.

Zymogen activation

The preproprotein is secreted into the small intestine and activated by proteolysis, offering a model for studying serine protease zymogen processing.

Chronic pancreatitis genetics

An inversion haplotype affecting CTRB1 and CTRB2 is associated with differential expression and increased risk of chronic pancreatitis.

Serine protease family studies

As a peptidase S1 family member in the chymotrypsin and elastase group, CTRB2 supports comparative work on related pancreatic proteases.

Background

CTRB2 frequently asked questions

What does CTRB2 do?

CTRB2 encodes a serine protease and a principal precursor of the pancreatic proteolytic enzymes. It is synthesised in pancreatic acinar cells and secreted into the small intestine, where proteolytic activation produces the functional enzyme.

What is the relationship between CTRB2 and CTRB1?

The CTRB2 gene is located head-to-head with the related CTRB1 gene. In an alternate haplotype found in some populations, a 16.6 Kb region is inverted and exon 1 with flanking sequence is swapped between the two genes.

Is CTRB2 linked to disease?

The inversion haplotype involving CTRB1 and CTRB2 is associated with differential gene expression and increased risk of chronic pancreatitis. SNP rs8048956 is diagnostic for this inversion. Mouse and rat orthologues are not given in the source data here.

Explore

Related targets

The neighbouring chymotrypsinogen gene CTRB1 and other pancreatic serine protease targets with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q6GPI1; product specifications from Assay Genie datasheets.

CTRB2 Product listing